Increased expression of annexin I and thioredoxin detected by two-dimensional gel electrophoresis of drug resistant human stomach cancer cells.
The therapy of advanced cancer using chemotherapy alone or in combination with radiation or hyperthermia yields an overall response rate of about 20-50%. This success is often marred by the development of resistance to cytostatic drugs. Our aim was to study the global analysis of protein expression in the development of chemoresistance in vitro. We therefore used a cell culture model derived from the gastric carcinoma cell line EPG 85-257P. A classical multidrug-resistant subline EPG85-257RDB selected to daunorubicin and an atypical multidrug-resistant cell variant EPG85-257RNOV selected to mitoxantrone, were analysed using two-dimensional electrophoresis in immobilized pH-gradients (pH 4.0-8.0) in the first dimension and linear polyacrylamide gels (12%) in the second dimension. After staining with coomassie brilliant blue, image analysis was performed using the PDQuest system. Spots of interest were isolated using preparative two-dimensional electrophoresis and subjected to microsequencing. A total of 241 spots from the EPG85-257RDB-standard and 289 spots from the EPG85-257RNOV-standard could be matched to the EPG85-257P-standard. Microsequencing after enzymatic hydrolysis in gel, mass spectrometric data and sequencing of the peptides after their fractionation using microbore HPLC identified that two proteins annexin I and thioredoxin were overexpressed in chemoresistant cell lines. Annexin I was present in both the classical and the atypical multidrug-resistant cells. Thioredoxin was found to be overexpressed only in the atypical multidrug-resistant cell line.
Sinha
P
P
Institut für Laboratoriumsmedizin und Pathobiochemie, Universitätsklinikum Charité, Berlin, Germany.
Hütter
G
G
Köttgen
E
E
Dietel
M
M
Schadendorf
D
D
Lage
H
H
D017305:Annexin A1 / Q000032:analysis / Q000378:metabolism*; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents / Q000494:pharmacology; D003630:Daunorubicin / Q000494:pharmacology; D018432:Drug Resistance, Multiple / Q000502:physiology; D015180:Electrophoresis, Gel, Two-Dimensional / Q000379:methods*; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008942:Mitoxantrone / Q000494:pharmacology; D017422:Sequence Analysis, DNA; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D013879:Thioredoxins / Q000032:analysis / Q000378:metabolism*; D014407:Tumor Cells, Cultured
D017305:Annexin A1; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D013879:Thioredoxins; D008942:Mitoxantrone; D003630:Daunorubicin